rs143780942

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 2P and 14B. PM5BP4_ModerateBP6_Very_StrongBS2

The NM_020822.3(KCNT1):​c.3001A>G​(p.Thr1001Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00021 in 1,573,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1001M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

KCNT1
NM_020822.3 missense

Scores

6
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 8.65

Publications

1 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr9-135784592-A-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 1328519.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.111849576).
BP6
Variant 9-135784592-A-G is Benign according to our data. Variant chr9-135784592-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 417214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNT1NM_020822.3 linkc.3001A>G p.Thr1001Ala missense_variant Exon 26 of 31 ENST00000371757.7 NP_065873.2 Q5JUK3-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNT1ENST00000371757.7 linkc.3001A>G p.Thr1001Ala missense_variant Exon 26 of 31 1 NM_020822.3 ENSP00000360822.2 Q5JUK3-3

Frequencies

GnomAD3 genomes
AF:
0.000165
AC:
24
AN:
145640
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00117
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000195
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000323
AC:
79
AN:
244396
AF XY:
0.000315
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00122
Gnomad NFE exome
AF:
0.000474
Gnomad OTH exome
AF:
0.000337
GnomAD4 exome
AF:
0.000214
AC:
306
AN:
1428126
Hom.:
0
Cov.:
34
AF XY:
0.000217
AC XY:
154
AN XY:
710104
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32572
American (AMR)
AF:
0.00
AC:
0
AN:
43514
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24962
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36904
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85724
European-Finnish (FIN)
AF:
0.00125
AC:
62
AN:
49602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4608
European-Non Finnish (NFE)
AF:
0.000193
AC:
211
AN:
1092058
Other (OTH)
AF:
0.000567
AC:
33
AN:
58182
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000165
AC:
24
AN:
145640
Hom.:
0
Cov.:
31
AF XY:
0.000227
AC XY:
16
AN XY:
70558
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
39488
American (AMR)
AF:
0.00
AC:
0
AN:
14256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3406
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4718
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4400
European-Finnish (FIN)
AF:
0.00117
AC:
11
AN:
9404
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
298
European-Non Finnish (NFE)
AF:
0.000195
AC:
13
AN:
66760
Other (OTH)
AF:
0.00
AC:
0
AN:
2024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000315
Hom.:
0
Bravo
AF:
0.000113
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000496
AC:
60

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Dec 31, 2016
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 12, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 20, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 14 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KCNT1: BS1 -

Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.0075
T
BayesDel_noAF
Uncertain
0.090
CADD
Benign
23
DANN
Benign
0.92
DEOGEN2
Benign
0.055
.;.;.;.;.;.;.;.;T;.
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.040
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.11
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
1.1
.;.;.;.;.;.;.;.;L;.
PhyloP100
8.6
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.78
.;.;N;.;.;.;.;.;N;N
REVEL
Uncertain
0.37
Sift
Benign
0.47
.;.;T;.;.;.;.;.;T;T
Sift4G
Benign
0.50
T;T;T;T;T;T;T;T;T;T
Polyphen
0.38
.;.;.;.;.;.;.;.;B;.
Vest4
0.96
MVP
0.70
MPC
0.67
ClinPred
0.079
T
GERP RS
4.6
Varity_R
0.14
gMVP
0.93
Mutation Taster
=32/68
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143780942; hg19: chr9-138676438; API